SCHEMBL9890979

SCHEMBL9890979

COc1cc(C)nc2c(C)c(C)ccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
MAPT P10636 2/20 0.50
CRHR1 P34998 1/20 0.47
GPR35 Q9HC97 1/20 0.45
KDM1A O60341 1/20 0.43
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
DHFR P00374 1/20 0.40
CASP2 P42575 1/20 0.39
ADORA1 P30542 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
PDPK1 O15530 1/20 0.38
DAPK3 O43293 1/20 0.38
PRKD3 O94806 1/20 0.38
FLT1 P17948 1/20 0.38
RPS6KA3 P51812 1/20 0.38
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31290693 0.87 MAPT (0.53) LMNAMAPTCRHR1GPR35KMT2A
SCHEMBL15028115 0.87 MAPT (0.53) LMNAMAPTCRHR1GPR35KMT2A
SCHEMBL9605485 0.83 MAPT (0.47) LMNAMAPTCRHR1KMT2ACYP1A2
SCHEMBL11941719 0.81 LMNA (0.48) LMNAMAPTCRHR1KDM1AKMT2A
SCHEMBL15576630 0.81 LMNA (0.48) LMNAMAPTCRHR1KDM1AKMT2A
SCHEMBL10099092 0.79 MAPT (0.59) LMNAMAPTCRHR1GPR35KMT2A
SCHEMBL8278961 0.78 LMNA (0.39) LMNAMAPTCRHR1GPR35KDM1A
SCHEMBL26766431 0.76 CRHR1 (0.58) LMNAMAPTCRHR1KDM4EALDH1A1
SCHEMBL17911945 0.76 CRHR1 (0.45) MAPTCRHR1DHFRADORA1KDM4E
SCHEMBL23714063 0.74 MAPT (0.49) LMNAMAPTCRHR1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142929-A1 PROCESS FOR PREPARING SULFONYL QUINOLINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142929-A1 PROCESS FOR PREPARING SULFONYL QUINOLINES GYS2, CYP3A7, GBA1 LMNA 2710/4885MAPT 4747/4885CRHR1 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.